HPLC separation of enterobactin and linear 2,3-dihydroxybenzoylserine derivatives: a study on mutants of Escherichia coli defective in regulation (fur), esterase (fes) and transport (fepA).

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 8148617)

Published in Biometals on April 01, 1994

Authors

G Winkelmann1, A Cansier, W Beck, G Jung

Author Affiliations

1: Institut für Biologie, Mikrobiologie & Biotechnologie, Universität Tübingen, Germany.

Articles by these authors

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (1991) 13.90

Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem (1999) 6.44

Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature (1990) 6.23

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature (1989) 5.08

Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med (2001) 5.06

Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature (1988) 4.41

Exact prediction of a natural T cell epitope. Eur J Immunol (1991) 2.90

Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J (1994) 2.86

Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone. J Immunol (1996) 2.70

Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J Exp Med (1991) 2.48

Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol (1990) 2.37

Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J Exp Med (1997) 2.33

Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur J Biochem (1988) 2.32

Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives. FEBS Lett (1999) 2.16

Maltophilin: a new antifungal compound produced by Stenotrophomonas maltophilia R3089. J Antibiot (Tokyo) (1996) 2.07

Epidemiology and cost of ventral hernia repair: making the case for hernia research. Hernia (2011) 2.06

Epidermin: sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic. Eur J Biochem (1986) 2.04

Structure of the pheromone peptide of the Staphylococcus epidermidis agr system. FEBS Lett (1998) 1.96

T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia. Hepatology (1996) 1.88

Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch Microbiol (1989) 1.85

Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med (1997) 1.81

Human heart transplantation--the pre-operative assessment. S Afr Med J (1967) 1.80

Characterization of Cd, Zn-thionein (metallothionein) isolated from rat and chicken liver. Eur J Biochem (1973) 1.79

Allele-specific peptide ligand motifs of HLA-C molecules. Proc Natl Acad Sci U S A (1993) 1.77

Identification of Trk binding sites for SHC and phosphatidylinositol 3'-kinase and formation of a multimeric signaling complex. J Biol Chem (1993) 1.73

Fengycin--a novel antifungal lipopeptide antibiotic produced by Bacillus subtilis F-29-3. J Antibiot (Tokyo) (1986) 1.64

Melittin and a chemically modified trichotoxin form alamethicin-type multi-state pores. Biochim Biophys Acta (1983) 1.63

New biologically active hybrid bacteriocins constructed by combining regions from various pediocin-like bacteriocins: the C-terminal region is important for determining specificity. Appl Environ Microbiol (1996) 1.61

Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity (1995) 1.59

Identification and analysis of the balhimycin biosynthetic gene cluster and its use for manipulating glycopeptide biosynthesis in Amycolatopsis mediterranei DSM5908. Antimicrob Agents Chemother (1999) 1.58

Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics (1994) 1.58

Protein engineering of lantibiotics. Antonie Van Leeuwenhoek (1996) 1.54

Structural gene isolation and prepeptide sequence of gallidermin, a new lanthionine containing antibiotic. FEMS Microbiol Lett (1989) 1.53

In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur J Immunol (2000) 1.53

Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries. Proc Natl Acad Sci U S A (1997) 1.53

Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiology (1988) 1.51

Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells. Eur J Immunol (1991) 1.51

Isolation and characterization of staphyloferrin A, a compound with siderophore activity from Staphylococcus hyicus DSM 20459. FEMS Microbiol Lett (1990) 1.49

Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes. J Immunol (1985) 1.46

Staphyloferrin A: a structurally new siderophore from staphylococci. Eur J Biochem (1990) 1.45

Clinical efficacy of the polyurethane stent without fluoroscopic guidance in the treatment of nasolacrimal duct obstruction. Ophthalmology (2000) 1.44

Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo. J Immunol (1996) 1.43

Feline demodicosis caused by concurrent infestation with Demodex cati and an unnamed species of mite. Vet Rec (2005) 1.43

An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics (2000) 1.42

Myosin IB null mutants of Dictyostelium exhibit abnormalities in motility. Cell Motil Cytoskeleton (1991) 1.42

Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression. Eur J Immunol (1990) 1.41

In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide. J Biol Chem (1994) 1.40

Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. Eur J Biochem (1990) 1.40

Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation. Anal Biochem (1994) 1.40

H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies. Eur J Immunol (1999) 1.38

Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis. Infect Immun (1998) 1.38

Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules. J Exp Med (1995) 1.37

Biosynthesis of the orthosomycin antibiotic avilamycin A: deductions from the molecular analysis of the avi biosynthetic gene cluster of Streptomyces viridochromogenes Tü57 and production of new antibiotics. Chem Biol (2001) 1.36

Molecular characterization of lantibiotic-synthesizing enzyme EpiD reveals a function for bacterial Dfp proteins in coenzyme A biosynthesis. J Biol Chem (2000) 1.36

Characterization of reutericyclin produced by Lactobacillus reuteri LTH2584. Appl Environ Microbiol (2000) 1.33

High-performance liquid chromatography of siderophores from fungi. Biol Met (1988) 1.32

Oxidative decarboxylation of peptides catalyzed by flavoprotein EpiD. Determination of substrate specificity using peptide libraries and neutral loss mass spectrometry. J Biol Chem (1995) 1.32

On the transport of tripeptide antibiotics in bacteria. Eur J Biochem (1976) 1.31

Purification and chemical characterization of staphyloferrin B, a hydrophilic siderophore from staphylococci. Biometals (1993) 1.31

Conformational and nucleic acid binding studies on the synthetic nucleocapsid protein of HIV-1. J Mol Biol (1993) 1.31

Conformational changes of alamethicin induced by solvent and temperature. A 13C-NMR and circular-dichroism study. Eur J Biochem (1975) 1.31

Functions of unconventional myosins. Curr Opin Cell Biol (2000) 1.31

[Dissociation equilibrium of glutathione. A Fourier transform-13C-NMR spectroscopic study of pH-dependence and of charge densities]. Eur J Biochem (1972) 1.30

Idiopathic mitral subannular left ventricular aneurysm in the Bantu. Am Heart J (1969) 1.30

Ornibactins--a new family of siderophores from Pseudomonas. Biometals (1993) 1.30

Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147. J Biol Chem (1999) 1.29

Amino acid requirements of the nucleocapsid protein of HIV-1 for increasing catalytic activity of a Ki-ras ribozyme in vitro. J Mol Biol (1994) 1.29

Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl Environ Microbiol (1998) 1.28

Isolation and biological characterization of staphyloferrin B, a compound with siderophore activity from staphylococci. FEMS Microbiol Lett (1994) 1.28

Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein. Hoppe Seylers Z Physiol Chem (1983) 1.26

Identification of receptor binding sites by competitive peptide mapping: phages T1, T5, and phi 80 and colicin M bind to the gating loop of FhuA. J Bacteriol (1995) 1.26

Purification of yersiniabactin: a siderophore and possible virulence factor of Yersinia enterocolitica. J Gen Microbiol (1993) 1.26

Prepeptide sequence of cinnamycin (Ro 09-0198): the first structural gene of a duramycin-type lantibiotic. Eur J Biochem (1991) 1.26

Structure-function relationships in the tryptophan-rich, antimicrobial peptide indolicidin. J Pept Sci (2001) 1.25

Tyrosine 785 is a major determinant of Trk--substrate interaction. EMBO J (1993) 1.25

Isolation and characterization of the three polypeptide components of 4-chlorobenzoate dehalogenase from Pseudomonas sp. strain CBS-3. Biochemistry (1992) 1.24

Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules. Nature (1993) 1.23

Voltage-dependent channel formation by rods of helical polypeptides. J Membr Biol (1986) 1.23

Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis. J Gen Virol (1997) 1.22

Structural fluctuations of a helical polypeptide traversing a lipid bilayer. Proc Natl Acad Sci U S A (1988) 1.21

Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics (1994) 1.20

Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus. Hepatology (1997) 1.20

Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C. J Hepatol (1999) 1.20

Isolation and characterization of genetically engineered gallidermin and epidermin analogs. Appl Environ Microbiol (1995) 1.19

Hematopoietic and reproductive hazards of Korean electronic workers exposed to solvents containing 2-bromopropane. Scand J Work Environ Health (1996) 1.19

Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study. J Clin Oncol (1984) 1.19

Lantibiotics and microcins: polypeptides with unusual chemical diversity. Curr Opin Chem Biol (2000) 1.18

Stable multicopy vectors for high-level secretion of recombinant human serum albumin by Kluyveromyces yeasts. Biotechnology (N Y) (1991) 1.18

Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5. Appl Environ Microbiol (1996) 1.18

Rhizocticin A, an antifungal phosphono-oligopeptide of Bacillus subtilis ATCC 6633: biological properties. Arch Microbiol (1990) 1.18

Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide. J Exp Med (1991) 1.17

Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus. J Virol (1997) 1.17

Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics (1993) 1.17

The role of cumulative physical work load in lumbar spine disease: risk factors for lumbar osteochondrosis and spondylosis associated with chronic complaints. Occup Environ Med (2001) 1.17

Persistent polyclonal B lymphocytosis with binucleated lymphocytes: a study of 25 cases. Groupe Français d'Hématologie Cellulaire. Br J Haematol (1999) 1.16

Analysis of surgical versus medical therapy in active complicated native valve infective endocarditis. Am J Cardiol (1983) 1.16

Peptide siderophores. J Pept Sci (1998) 1.15

Characterization of ferrioxamine E as the principal siderophore of Erwinia herbicola (Enterobacter agglomerans). Biol Met (1988) 1.15

Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest (1997) 1.14